News

The National Academy of Medicine today released a discussion paper examining the experiences of hospitals and health systems during the COVID-19 pandemic, and opportunities to leverage the lessons of COVID-19 to support performance improvements to the sector more broadly.

In a letter to the editor published today by the Washington Post, AHA President and CEO Rick Pollack responds to a recent article in the paper’s Business section, which suggested COVID-19 relief funds enriched “wealthy” hospital systems. 

The Centers for Medicare & Medicaid Services late today issued a proposed rule for the inpatient psychiatric facility prospective payment system for fiscal year 2022.

The Centers for Medicare & Medicaid Services today issued a brief proposed rule for the inpatient rehabilitation facility prospective payment system for fiscal year 2022.

Many of the digital solutions we relied on during the pandemic will remain, making digital health equity, including digital access and literacy, even more important. As hospitals and health systems design and implement digital solutions, it will be imperative to take proactive steps so all individuals have the opportunity to engage with these tools.

The U.S. Court of Appeals for the 10th Circuit yesterday affirmed a district court decision rejecting an Albuquerque physician practice’s claims that Presbyterian Healthcare Services engaged in exclusionary or anticompetitive conduct under the Sherman Act.

Health Facilities Management, the official magazine of AHA’s American Society for Health Care Engineering, looks at factors to consider when creating space for patient surges.

Learn how hospital and health system leaders such as Richard Bagley, senior vice president, chief supply chain officer, Penn State Health, are looking beyond the pandemic to address long-standing vulnerabilities in the health care supply chain during crisis situations.

The Food and Drug Administration authorized for emergency use the first prescription antibody test that allows individuals to collect a finger-stick dried blood sample at home for analysis at a Symbiotica laboratory when a health care provider deems it appropriate.

The Moderna COVID-19 vaccine continued to protect 33 healthy adults six months after receiving the second dose, according to an ongoing clinical trial examining the vaccine’s durability, published in the New England Journal of Medicine.

The AHA unveiled several new resources to aid hospitals’ and health systems’ efforts to increase the public’s confidence in COVID-19 vaccines.

The Federal Emergency Management Agency announced additional assistance under its public assistance program for eligible costs to safely reopen and operate certain private nonprofits in response to the COVID-19 emergency, including private nonprofit medical facilities.

All U.S. adults will become eligible for the COVID-19 vaccine by April 19, President Biden announced. That’s a couple weeks sooner than the May 1 target he announced last month.

Join the AHA and its American Organization for Nursing Leadership April 7 at 1 p.m. ET for a panel discussion on ways to identify and address inequities in maternal care, empower women of color and create solutions to improve maternal health equity.

The Centers for Medicare & Medicaid Services released a toolkit for qualified health plans applying for plan year 2022 certification, and guidance to help applicants identify essential community providers and meet network adequacy standards.

The FBI and Cybersecurity and Infrastructure Security Agency advised organizations to protect their computer networks from known vulnerabilities in FortiOS, the operating system for the Fortinet network security system.

Johnson & Johnson will soon start testing its COVID-19 vaccine candidate in U.S. adolescents, the company announced.

We know that a person’s health is influenced more by their social and economic circumstances than by access to medical services. However, making a real difference for people who struggle with social needs remains a significant challenge. 

The Biden-Harris administration sent Congress its first-year drug policy priorities, as required by each new administration. 

The Food and Drug Administration alerted health care providers to the risk of infections associated with reprocessed urological endoscopes, used to view and access the urinary tract, citing over 450 medical device reports since 2017 describing post-procedure patient infections or other possible contamination.